The Use of EndoFlip as a Clinical Tool for the Prediction of Postoperative GERD After Sleeve Gastrectomy
NCT ID: NCT05690022
Last Updated: 2023-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2023-02-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
NCT04411823
Can EndoFLIP Improve Quality of Life Before and After Fundoplication?
NCT06159972
Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy
NCT05486169
Postoperative Gastroesophageal Reflux Symptoms After Laparoscopic Sleeve Gastrectomy Based on the Presence of Preoperative Symptoms
NCT06835933
Laparoscopic Sleeve Gastrectomy and Gastroesophageal Acid Reflux
NCT02012894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before sleeve gastrectomy
Gastroesophageal Reflux Disease (GERD) will be evaluated before surgery. EndoFlip, gastroscopy, pH-study and GERD-Health-Related Quality of Life Questionnaire will be realized for all patients.
No interventions assigned to this group
Sleeve gastrectomy
After the surgical intervention, new onset or worsening of GERD will be evaluated.
sleeve gastrectomy
Patients will be recruited for a sleeve gastrectomy according to the guidelines of the National Institute of Health.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sleeve gastrectomy
Patients will be recruited for a sleeve gastrectomy according to the guidelines of the National Institute of Health.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Erosive esophagitis at preoperative gastroscopy
* Barrett's metaplasia/dysplasia at preoperative gastroscopy
* Revision surgery before the end of the study
* Pregnancy during the study period
* Actively bleeding esophageal varices
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laurent Biertho
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François-Charles Malo
Role: PRINCIPAL_INVESTIGATOR
Université de Sherbrooke
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EndoFlip
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.